Royalty Pharma plc (RPRX)
NASDAQ·Healthcare·Biotechnology
$49.40
-0.50%
Mkt Cap $21.20B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 11, 2026 | $806.96M | $874.00M | +8.31% | $1.29 | $1.46 | +13.18% | — | — |
| Q4 2025 Nov 5, 2025 | $717.38M | $609.29M | -15.07% | $0.99 | $1.17 | +17.71% | — | — |
| Q3 2025 Aug 6, 2025 | $672.99M | $578.66M | -14.02% | $1.03 | $1.14 | +10.68% | — | — |
| Q2 2025 May 8, 2025 | $705.34M | $568.25M | -19.44% | $0.95 | $1.06 | +11.23% | — | — |
| Q1 2025 Feb 11, 2025 | $687.10M | $594.00M | -13.55% | $0.99 | $1.15 | +16.16% | — | — |
| Q4 2024 Nov 6, 2024 | $696.92M | $564.69M | -18.97% | $0.93 | $1.04 | +12.07% | — | — |
| Q3 2024 Aug 8, 2024 | $627.42M | $537.27M | -14.37% | $0.96 | $0.96 | -0.52% | — | — |
| Q2 2024 May 9, 2024 | $665.57M | $567.98M | -14.66% | $0.99 | $0.98 | -0.71% | — | — |
| Q1 2024 Feb 15, 2024 | $673.65M | $596.00M | -11.53% | $1.01 | $1.15 | +13.86% | — | — |
| Q4 2023 Nov 8, 2023 | $614.36M | $536.31M | -12.70% | $0.81 | $0.79 | -2.47% | — | — |
| Q3 2023 Aug 8, 2023 | $536.59M | $538.20M | +0.30% | $0.83 | $0.85 | +2.41% | — | — |
| Q2 2023 May 9, 2023 | $852.90M | $683.97M | -19.81% | $1.32 | $1.60 | +21.21% | — | — |
| Q1 2023 Feb 15, 2023 | $1.06B | $565.75M | -46.83% | $1.56 | $1.56 | +0.00% | — | — |
| Q4 2022 Nov 8, 2022 | $586.32M | $573.46M | -2.19% | $0.71 | $0.73 | +2.82% | — | — |
| Q3 2022 Aug 4, 2022 | $528.36M | $535.96M | +1.44% | $0.78 | $0.79 | +1.28% | — | — |
| Q2 2022 May 5, 2022 | $597.01M | $562.05M | -5.86% | $0.72 | $0.61 | -15.28% | — | — |
| Q1 2022 Feb 15, 2022 | $552.06M | $575.70M | +4.28% | $0.79 | $0.80 | +1.27% | — | — |
| Q4 2021 Nov 10, 2021 | $551.82M | $585.77M | +6.15% | $0.69 | $0.73 | +5.80% | — | — |
| Q3 2021 Aug 11, 2021 | $554.96M | $554.96M | +0.00% | $0.70 | $0.71 | +1.43% | — | — |
| Q2 2021 May 11, 2021 | $888.63M | $573.03M | -35.52% | $0.65 | $0.67 | +3.08% | — | — |